BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,869,636 | -39.0% | 76,037 | +25.2% | 0.04% | -20.0% |
| Q1 2022 | $4,708,000 | +235.3% | 60,721 | +264.7% | 0.04% | +246.2% |
| Q1 2021 | $1,404,000 | +5.1% | 16,650 | 0.0% | 0.01% | +8.3% |
| Q4 2020 | $1,336,000 | -31.2% | 16,650 | -31.0% | 0.01% | -42.9% |
| Q3 2020 | $1,941,000 | -78.0% | 24,135 | -76.5% | 0.02% | -79.6% |
| Q2 2020 | $8,825,000 | +54.8% | 102,500 | +46.0% | 0.10% | +30.4% |
| Q1 2020 | $5,701,000 | +226.5% | 70,219 | +236.2% | 0.08% | +315.8% |
| Q4 2019 | $1,746,000 | -83.2% | 20,886 | -82.4% | 0.02% | -83.9% |
| Q3 2019 | $10,383,000 | +23.4% | 118,703 | +15.6% | 0.12% | +32.6% |
| Q2 2019 | $8,412,000 | -16.6% | 102,713 | -17.2% | 0.09% | -8.2% |
| Q1 2019 | $10,089,000 | +42.9% | 124,076 | +15.7% | 0.10% | +32.9% |
| Q4 2018 | $7,060,000 | -12.4% | 107,259 | +2.6% | 0.07% | +10.6% |
| Q3 2018 | $8,062,000 | +9.0% | 104,572 | +4.4% | 0.07% | +10.0% |
| Q2 2018 | $7,393,000 | +40.3% | 100,124 | +23.6% | 0.06% | +39.5% |
| Q1 2018 | $5,268,000 | -2.7% | 80,996 | -3.3% | 0.04% | -2.3% |
| Q4 2017 | $5,413,000 | -8.0% | 83,745 | -10.7% | 0.04% | -6.4% |
| Q3 2017 | $5,882,000 | +10.5% | 93,734 | +6.6% | 0.05% | +6.8% |
| Q2 2017 | $5,325,000 | +26.4% | 87,959 | +8.2% | 0.04% | +25.7% |
| Q1 2017 | $4,214,000 | +12.3% | 81,257 | -4.0% | 0.04% | +25.0% |
| Q4 2016 | $3,754,000 | -71.0% | 84,655 | -68.9% | 0.03% | -71.4% |
| Q3 2016 | $12,940,000 | -71.4% | 271,831 | -72.8% | 0.10% | -71.3% |
| Q2 2016 | $45,238,000 | +21.1% | 1,000,388 | +10.0% | 0.34% | +24.8% |
| Q1 2016 | $37,352,000 | +245.3% | 909,244 | +220.7% | 0.27% | +251.3% |
| Q4 2015 | $10,816,000 | +340.7% | 283,520 | +279.4% | 0.08% | +333.3% |
| Q3 2015 | $2,454,000 | -38.9% | 74,722 | +30.1% | 0.02% | -30.8% |
| Q2 2015 | $4,015,000 | -66.3% | 57,422 | -67.0% | 0.03% | -54.4% |
| Q1 2015 | $11,907,000 | -3.9% | 173,822 | +2.8% | 0.06% | +9.6% |
| Q4 2014 | $12,395,000 | -38.6% | 169,122 | -39.9% | 0.05% | -35.8% |
| Q3 2014 | $20,187,000 | -2.9% | 281,272 | -2.2% | 0.08% | -5.8% |
| Q2 2014 | $20,798,000 | -1.1% | 287,672 | +0.7% | 0.09% | -1.1% |
| Q1 2014 | $21,023,000 | +12.7% | 285,722 | +6.5% | 0.09% | +10.1% |
| Q4 2013 | $18,662,000 | +6.0% | 268,350 | +0.1% | 0.08% | -2.5% |
| Q3 2013 | $17,605,000 | -52.2% | 268,000 | -49.6% | 0.08% | -11.0% |
| Q2 2013 | $36,818,000 | – | 531,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |